NMR
NOMURA HOLDINGS INC
NYSE · Financial Services · Financial - Capital Markets · JP
$9.12
−1.30%Year over year
Reported trailing growth
- Revenue
- -2.4%
- EBITDA
- +15.3%
- EBIT
- +11.7%
- EPS
- +8.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -40.3%
- EBITDA
- +24.9%
- EPS
- +4.8%
Three-year CAGR
- Revenue
- +27.5%
- EBITDA
- +42.3%
- EBIT
- +53.4%
- Net income
- +57.4%
- EPS
- +58.6%
- Free cash flow
- -37.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026